RARA CRAFT DATABASE for FDA Medical Devices
510(k)K243685

FDA DEVICE FACTS

MammoScreen BD

Therapixel

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

AI/MLPCCP: Authorized
DECISION DATEAugust 22, 2025PRODUCT CODEQIHCLINICAL AREARadiology

Indications for use

MammoScreen® BD is a software application intended for use with compatible full-field digital mammography and digital breast tomosynthesis systems. MammoScreen BD evaluates the breast tissue composition to provide an ACR BI-RADS 5th Edition breast density category. The device is intended to be used in the population of asymptomatic women undergoing screening mammography who are at least 40 years old. MammoScreen BD only produces adjunctive information to aid interpreting physicians in the assessment of breast tissue composition. It is not a diagnostic software. Patient management decisions should not be made solely based on analysis by MammoScreen BD.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 12, 2026